CASE DISCUSSION
CAR T Cells in Cancer Gene Therapy
Presented India by Dr. Shibichakravarthy KannanViews
4,905
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
CAR T-cell therapy is a groundbreaking approach in cancer gene therapy that harnesses a patient’s immune cells to target and destroy cancer cells. In this technique, T-cells are genetically modified to express chimeric antigen receptors (CARs) that specifically recognize cancer cells. Once...
Case Summary
- The speaker introduces their diagnostics portfolio, highlighting liquid biopsy as the flagship product, alongside therapeutic efforts focused on immuno-oncology, particularly cell-based immunotherapies like CAR-T cells. Other therapies mentioned include CAR-NK cells, macrophages, T-regs, and tumor-infiltrating lymphocytes, but the main focus is on CAR-T cells due to their clinical approval and market presence.
Speaker Profile
Dr. Shibichakravarthy Kannan
Precision Oncology, Founder & CEO in Oncophenomics Inc., HyderabadDisclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.